217 filings
Page 7 of 11
8-K
qtvd5f1j0ee2bi2xd i0
3 Jan 13
Endologix Appoints Shelley B. Thunen Chief Financial Officer
12:00am
8-K
un1gna 3206gm8
4 Dec 12
Endologix Announces CFO Retirement
12:00am
8-K
3mdtmw2haxo2
28 Nov 12
Departure of Directors or Certain Officers
12:00am
8-K
ot3o4b7
25 Oct 12
Endologix Reports 20% Revenue Growth for the Third Quarter 2012
12:00am
8-K
howbx39b4k6nl2
17 Oct 12
Endologix Settles Patent Litigation with Cook Medical
12:00am
8-K
5oipemle7eeq
3 Oct 12
Departure of Directors or Certain Officers
12:00am
8-K
dmlw0r0qxpqxmu
15 Aug 12
Changes in Registrant's Certifying Accountant
12:00am
8-K
jdde5f5shuiembbul3
26 Jul 12
Endologix Reports 33% Revenue Growth for the Second Quarter 2012
12:00am
8-K/A
e286kytv121j
11 Jun 12
Other Events
12:00am
8-K
r5z7cf 406
31 May 12
Endologix Announces Public Offering of 2.7 Million Shares of Common Stock
12:00am
8-K
aj7yvwpgh gv5ck2in
30 May 12
Departure of Directors or Certain Officers
12:00am
8-K
hmn2ez1
26 Apr 12
Endologix Reports 32% Revenue Growth for the First Quarter 2012
12:00am
8-K
kyhmg clh
28 Mar 12
Appoints John McDermott to Chairman of the Board of Directors
12:00am
8-K
j9edyh
24 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
hqdd 77y3g
22 Feb 12
Endologix Reports 24% and 22% Revenue Growth for the Full Year and Fourth Quarter 2011
12:00am
8-K
9pk346dkj di6
1 Nov 11
Entry into a Material Definitive Agreement
12:00am
8-K
528tyee5ors azttjqu
27 Oct 11
Endologix Reports 25% Third Quarter 2011 Revenue Growth
12:00am
8-K
oq6jdezugcfmpy
27 Jul 11
Endologix Reports 22% Second Quarter 2011 Revenue Growth
12:00am
8-K
ar5hxosxx
9 Jun 11
Departure of Directors or Certain Officers
12:00am
8-K
bdh88yo 9n6e3
1 Jun 11
Submission of Matters to a Vote of Security Holders
12:00am